Graid Technology Inc.
Protecting NVMe-based data from the desktop to the cloud: all-new SupremeRAID™ SR-1001 delivers superior performance and flexibility for tower and edge servers, professional workstations, and gaming desktops.
SANTA CLARA, CA / ACCESSWIRE / January 25, 2024 / Graid Technology, an industry trailblazer in GPU-based RAID for NVMe, proudly announces the groundbreaking release of SupremeRAID™ SR-1001. This innovative GPU-based RAID solution is designed to maximize NVMe SSD performance while eliminating CPU cycle consumption and avoiding throughput bottlenecks. Utilizing patented out-of-path RAID protection technology, data travels directly from the CPU to the NVMe SSDs, ensuring unmatched flexibility, unprecedented performance, and overall superior value.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.NVMe SSDs, with their high-speed performance and low latency, significantly enhance tasks across CAD, video editing, IoT, and gaming. Faster loading times, improved rendering, quick file transfers, smooth playback, efficient data processing, and reduced latency contribute to overall superior performance. But traditional RAID methods introduce bottlenecks, limiting the performance of NVMe SSDs in critical applications.
GPU-based SupremeRAID™ SR-1001 supports up to 8 NVMe SSDs and delivers superior performance and flexibility for towers and edge servers, professional workstations, and gaming desktops. SupremeRAID™ SR-1001 is the perfect storage choice for engineers, videographers, telcos, CSPs, and MSPs. Its powerful performance capabilities are well-suited for applications such as CAD, video editing, IoT, and gaming.
"As NVMe SSDs play a crucial role in cloud, core, and edge infrastructure, the demand for enhanced data protection without compromising performance is evident," said Leander Yu, President and CEO of Graid Technology. "SupremeRAID™ SR-1001 addresses this need by delivering best-in-class performance and airtight data protection while optimizing throughput, parallelism, and latency, ensuring seamless performance at the edge. We are excited to add the SR-1001 to the SupremeRAID™ suite of products."
Graid Technology continues to lead the industry with innovative storage solutions, ensuring optimal NVMe SSD performance and superior data protection across diverse applications. The SupremeRAID™ SR-1001 is available immediately through all Graid Technology resale partners and distributors worldwide. To learn more, visit https://www.graidtech.com/product/sr-1001.
Graid Technology, Protecting NVMe-based Data from The Desktop To The Cloud With A Full Suite of Products:
- SupremeRAID™ SR-1001:
PCIe Gen 3 card supporting up to 8 SSDs, designed for 1U tower and edge servers, professional workstations, and gaming desktops. - SupremeRAID™ SR-1000:
PCIe Gen 3 card supporting up to 32 SSDs, catering to 1U cloud and enterprise servers. - SupremeRAID™ SR-1010:
PCIe Gen 4 card supporting up to 32 SSDs, ideal for 2U cloud and enterprise servers
About Graid Technology
Graid Technology, led by a dedicated team of experts with decades of experience in the SDS, ASIC, and storage industries, continues to push boundaries in data storage innovation with our full suite of SupremeRAID™ products, leveraging GPU acceleration to maximize enterprise SSD performance. The company's headquarters in Silicon Valley, supported by an R&D center in Taiwan, symbolizes our global commitment to pioneering advancements in storage solutions. Visit our website or connect with us on Twitter or LinkedIn.
Contact Information:
Andrea Eaken
Director of Marketing, Americas & EMEA | Graid Technology
andrea.eaken@graidtech.com
949-742-9928
Related Files
2024 SupremeRAID SR-1001 Brochure Specs.pdf
SOURCE: Graid Technology Inc.
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target12.1.2026 14:05:00 CET | Press release
Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026. With the full deployment of Datavault AI's nodes across 100+ cities throughout the United States, the 2027 revenue target is $2.0 to $3.0 billion for 2027. New York and Philadelphia edge network activation positions Datavault AI to potentially capture a significant share of the insurance and financial sectors, the healthcare industry, and enterprise opportunities. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies, today highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform. This
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 12:00:00 CET | Press release
On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom